| Literature DB >> 28093434 |
Philip Kofoed Månsson1, Sofia Johansson1, Morten Ziebell1, Marianne Juhler1.
Abstract
OBJECTIVE: The objective of this study is to review our experience of shunt surgery by investigating 40 years of development in terms of rates of revision and infection, shunt survival and risk factors. DESIGN AND PARTICIPANTS: Medical records and operative reports were reviewed retrospectively for all patients who underwent primary shunt surgery at our department in the years 2010 to 2012. All results were compared with a previous study from our department. A mixed population consisting of 434 patients was included. Adults (≥15 years) accounted for 89.9% of all patients and the mean follow-up time was 1.71 years.Entities:
Keywords: Hydrocephalus; NEUROSURGERY
Mesh:
Year: 2017 PMID: 28093434 PMCID: PMC5253591 DOI: 10.1136/bmjopen-2016-013389
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Flow chart presenting the inclusion and exclusion of patients. Reading the operative reports revealed that 23 patients did not undergo a CSF shunt procedure. A total of 168 patients were excluded because of previous shunt surgery and 4 patients were excluded because no follow-up information was available leaving 434 patients in the study. CSF, cerebrospinal fluid; VA-shunt, ventriculoatrial-shunt; VP-shunt, ventriculoperitoneal-shunt.
Demographics and characteristics of patients
| Total patients | n=434 | ||||
|---|---|---|---|---|---|
| n | Per cent | n | Per cent | ||
| Age group (years) | Level of brain injury | ||||
| <1 | 22 | 5.1 | GCS 14–15 | 251 | 61.2 |
| 1–14 | 22 | 5.1 | GCS 9–13 | 116 | 28.3 |
| ≥15 | 390 | 89.9 | GCS 3–8 | 43 | 10.5 |
| Distal placement | Missing | 24 | |||
| Atrial | 4 | 0.9 | Surgeon | ||
| Peritoneal | 430 | 99.1 | Registrar | 105 | 24.2 |
| Diagnosis | Trainee | 131 | 30.2 | ||
| Congenital | 4 | 0.9 | Neurosurgeon | 198 | 45.6 |
| Infantile | 16 | 3.7 | Duration (min) | ||
| NPH | 126 | 29.0 | <30 | 74 | 17.1 |
| HPH | 267 | 61.5 | 30–59 | 284 | 65.4 |
| | 60–89 | 67 | 15.4 | ||
| | ≥90 | 9 | 2.1 | ||
| | Time | ||||
| | Day | 282 | 65.0 | ||
| | Evening | 140 | 32.3 | ||
| | Night | 12 | 2.8 | ||
| | AB prophylaxis | ||||
| Stenosis | 11 | 2.5 | Yes | 328 | 75.6 |
| Other | 10 | 2.3 | No | 44 | 10.1 |
| In treatment | 62 | 14.3 | |||
The seven categories of HPH aetiology are italicized. Space-occupying lesions include 59 patients with malignant brain tumours, 4 patients with benign intraventricular cysts and 4 patients with giant basilar aneurisms. IIH=idiopathic intracranial hypertension. Postinfectious include patients with hydrocephalus secondary to meningitis. Juvenile include children with a demonstrated increased intracranial pressure without any structural pathology on MRI. One patient did not fit into any of these categories.
AB prophylaxis, whether the patient receives antibiotic prophylaxis intraoperatively or is in a covering treatment; HPH, high-pressure hydrocephalus; NPH, normal-pressure hydrocephalus; Stenosis, aqueductal stenosis.
Figure 2Histogram showing the age distribution of patients at the time of primary shunt insertion. The bimodal distribution with a sharp peak <1 year of age and a broad peak covering the ages 48–80 years illustrates the occurrence of infantile hydrocephalus versus the dominance of NPH in the senior population. The low occurrence in the interim decades mainly contains cases with hydrocephalus related to other diseases; for example, SAH, tumours and trauma. NPH, normal-pressure hydrocephalus; SAH, subarchnoid haemorrhage.
Significant risk factors for shunt revision
| Rate of revision | 185/434=42.6% (CI 38.0 to 47.3) | |||
|---|---|---|---|---|
| Number with revision | p Value χ2 | p Value trend | ||
| Risk factor | n | % (CI) | ||
| Age group (years) | ||||
| <1 | 16 | 72.7 (54.1 to 91.3) | 0.005 | 0.001 |
| 1–14 | 12 | 54.5 (33.7 to 75.4) | ||
| ≥15 | 157 | 40.3 (35.4 to 45.1) | ||
| Diagnosis group | ||||
| Con+Inf+Stenosis | 19 | 61.3 (44.1 to 78.4) | 0.037 | − |
| NPH+HPH+Others | 166 | 41.2 (36.4 to 46.0) | ||
| Level of brain injury | ||||
| GCS 14-15 | 116 | 46.2 (40.0 to 52.4) | 0.016 | 0.018 |
| GCS 9-13 | 36 | 31.0 (22.6 to 39.5) | ||
| GCS 3-8 | 15 | 34.9 (20.6 to 49.1) | ||
High-risk diagnosis group=congenital+infantile+aqueductal stenosis.
Low-risk diagnosis group=normal-pressure hydrocephalus+high-pressure hydrocephalus+others.
Only significant risk factors for shunt revision are included in this table. Mantel-Haenszel test for trend is used as a supplement in the analysis of ordered variables with more than two categories.
Revision rates for the subgroups of HPH-patients based on aetiology are presented in online supplementary table SA.
GCS, Glasgow Coma Scale; HPH, high-pressure hydrocephalus; NPH, normal-pressure hydrocephalus.
Significant risk factors for shunt infection
| Rate of acute infection | 14/434=3.2% (CI 1.6 to 4.9) | |||||
|---|---|---|---|---|---|---|
| Rate of infection | 24/434=5.5% (CI 3.4 to 7.7) | |||||
| Number with acute infection | Number with infection | |||||
| Risk factor | n | Per cent (CI) | p Value χ2 | n | Per cent (CI) | p Value χ2 |
| Surgeon group | ||||||
| Non-specialist | 2 | 0.8 (0 to 2.0) | 9 | 3.8 (1.4 to 6.3) | 0.096 | |
| Neurosurgeon | 12 | 6.1 (2.7 to 9.4) | 15 | 7.6 (3.6 to 11.3) | ||
| Duration | ||||||
| Short <60 min | 8 | 2.2 (0.7 to 3.8) | 16 | 4.5 (2.3 to 6.6) | ||
| Long ≥60 | 6 | 7.9 (1.8 to 14.0) | 8 | 10.5 (3.6 to 17.4) | ||
| AB prophylaxis | ||||||
| Yes | 8 | 2.4 (0.8 to 4.1) | 0.012 | 15 | 4.6 (2.3 to 6.8) | 0.001 |
| No | 5 | 11.4 (2.0 to 20.7) | 8 | 18.2 (6.8 to 29.6) | ||
| In treatment | 1 | 1.6 (0 to 4.7) | 1 | 1.6 (0 to 4.7) | ||
For p=0.012 and p=0.001 the χ test criteria were not met.
Only significant risk factors for acute infection or infection overall are included in this table. Valid and significant p values are in boldface.
Non-specialist=registrar+trainee.
Analysis of risk factors for acute infection—univariate and multivariate analyses
| Risk factor | Logistic regression—effect of single independent risk factor | Multiple logistic regression—effect of each controlling for the others | ||||
|---|---|---|---|---|---|---|
| OR | CI for OR | p Value | OR | CI for OR | p Value | |
| Surgeon group | ||||||
| Neurosurgeon vs Non-specialist | 7.55 | 1.67 to 34.15 | 15.35 | 2.98 to 79.17 | ||
| Duration | ||||||
| Long ≥60 min vs Short <60 min | 3.75 | 1.26 to 11.14 | 8.20 | 2.34 to 28.79 | ||
| People in operating room | 0.57 | 0.28 to 1.17 | 0.124 | 0.64 | 0.31 to 1.30 | 0.22 |
| AB prophylaxis | ||||||
| No AB vs AB+In treatment | 5.43 | 1.73 to 17.00 | 8.45 | 2.30 to 31.11 | ||
AB prophylaxis: the odds of an acute infection in the subgroup of patients with no antibiotic prophylaxis are compared with the odds of an acute infection in patients already receiving antibiotic or those who received antibiotic prophylaxis intraoperatively.
Non-specialist=registrar+trainee.
Significant risk factors for acute infection in addition to number of people in operating room are analysed with logistic regression. Significant p values are in boldface.
Figure 3Kaplan-Meier plot of previous and present study showing the revision free shunt durability for all patients, n=884 and n=434 respectively. Note the difference in follow-up time resulting in disruption of the solid curve by time=4.94 years (maximum follow-up time in our study). With permission of Springer.4
Kaplan-Meier analysis
| Study or risk factor | Mean survival time | 1-year survival | 5-year survival | Log rank p Value |
|---|---|---|---|---|
| Study | ||||
| Present study 2010–2012 | 2.88 (2.66 to 3.10) | 66.2 (61.5 to 70.9) | 48.0 (41.1 to 54.9) | – |
| Previous study 1958–1989 | – | 57 (53 to 61) | 37 (32 to 42) | |
| Age group (years) | ||||
| <1 | 1.50 (0.85 to 2.15) | 52.6 (31.2 to 74.0) | 0.004 | |
| 1–14 | 2.27 (1.32 to 3.22) | 52.9 (31.5 to 74.3) | ||
| ≥15 | 2.98 (2.75 to 3.22) | 67.9 (63.0 to 72.8) | ||
| Diagnosis group | ||||
| Con+Inf+Stenosis | 1.98 (1.35 to 2.61) | 60.1 (42.7 to 77.5) | 0.069 | |
| NPH+HPH+Others | 2.94 (2.71 to 3.17) | 66.8 (61.9 to 71.7) | ||
Comparison of shunt survival in previous and present study—survival curves are shown in figure 3. Log Rank test is used to test for a significant influence on shunt survival of age group and diagnosis group in the present study.
p, 0.004 between <1 year and ≥15 years; p, 0.320 between <1 year and 1–14 years; p, 0.262 between 1–14 years and ≥15 years.
Time, 4.94 years is used to estimate the 5-year shunt survival in our study.
HPH, high-pressure hydrocephalus; NPH, normal-pressure hydrocephalus.
Surgical findings at first revision
| Cause of revision | n=185 | Per cent | p Value | |
|---|---|---|---|---|
| Proximal defect or obstruction | 0.169 | |||
| Obstruction | 12 | 6.5 | ||
| Disconnection | 17 | 9.2 | ||
| Proximal displacement | 0.657 | |||
| Distal defect or obstruction | ||||
| Distal displacement | 0.301 | |||
| Subcutaneous | 14 | 7.6 | ||
| Radiating pain | 6 | 3.2 | ||
| Valve defect | ||||
| Acute infection | 0.090 | |||
| Late infection | 0.128 | |||
| No abnormal findings | 0.984 | |||
| Others | ||||
| Over drainage | 24 | 13.0 | ||
| Risk of infection/wound | 7 | 3.8 | ||
| Others | 19 | 10.3 |
Proportion of all causes in present study increased (↑) or decreased (↓) compared to the previous study with corresponding p values for significant difference. Significant p values are en boldface.
The 19 causes classified as Others include: change to a different valve (6); shunt insertion into infected CSF (2); postoperative haemorrhage (2); haemorrhage not related to shunt (3); additional ventricle catheter (1); suspected infection without evidence (1); withdrawal (1); abdominal hernia (1); operational error (1); no description (1).
CSF, cerebrospinal fluid.
Comparison of previous and present study
| Previous study 1958–1989, % | Present study 2010–2012, % | Risk difference % (CI) | p Value | |
|---|---|---|---|---|
| Revision | 48.3 | 42.6 | −5.7 (−11.5 to 0.20) | 0.060 |
| Infection | 7.4 | 5.5 (4.1*) | −1.8 (−4.7 to 1.1) | 0.261 (0.039*) |
| Acute infection | 6.1 | 3.2 | 0.037 |
Pairwise comparison of the proportions is reported as risk difference with related p values indicating significant difference or not.
*To estimate the effect of antibiotic prophylaxis, all patients in present study with no antibiotic prophylaxis (n=44) were excluded resulting in a significant difference (p 0.039) in risk of infection for all patients who followed the current regimen.
As well as comparing the 2010–2012 cohort with the entire 1958–1989 cohort, the new cohort is compared to three individual time periods in the previous study and presented in the table in italics. The rate of revision was significantly higher (p 0.001) in the first two time periods compared to the 2010–2012 cohort, but it was significantly lower in the latest decade (p 0.010). Though the rate of infection was remarkably lower in the earliest time period, compared to the 2010–2012 cohort none of the three time periods had a significantly different rate of infection.